SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Trillium Therapeutics
An SI Board Since February 2014
Posts SubjectMarks Bans Symbol
294 39 0 TRIL
Emcee:  tuck Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
194Thanks! (eom)scaram(o)uche-6/11/2018
193Also found AWM Trillium info here: fintel.io (Sort alphabetically on Security coBulbaMan-6/11/2018
192>> Hope the Forty Seven IPO catches.... << Needs a reverse split, scaram(o)uche-6/11/2018
191Just parking a link. Don't know if this is THE preferred, if it's just scaram(o)uche-6/11/2018
190Yeah Rick, I was surprised SURF didn’t get an IPO surge, actually closing down oBulbaMan-6/9/2018
189Market cap $400m..... sec.gov One product in clinical testing, phase I. (I knscaram(o)uche-6/9/2018
188>>> “...for allowing that last round of hiring to be sourced from a VanBulbaMan-6/8/2018
187So Nic finally had the nuts to hire the best person available? Kudos!! Needed dscaram(o)uche-6/7/2018
186Just absolutely disgusting. jay arnold? @jayabacus10h10 hours ago More On closcaram(o)uche-6/6/2018
185Fourty Seven files for IPO. It will have 177M shares outstanding after offeringsemi_infinite -6/1/2018
184Once again, shareholders are paying for the PD1 or PDL1 inhibitor. Or perhaps Dscaram(o)uche-5/30/2018
183Thnx, indeed very good results for small # subjects enrolled. CRs after Rituxan Miljenko Zuanic-5/18/2018
182Could this be the institutional recreation to 47 data? d18rn0p25nwr6d.cloudfronsemi_infinite -5/17/2018
181Competitor 47 out with good ASCO data: Forty Seven P1/2 data Cheers, Tucktuck-5/17/2018
180I took bite size chunks when it dropped below $6 recently. It seems the probabisemi_infinite -5/16/2018
179I have bought a little more over the last few weeks. Breaking the T-cell group iBiomaven-5/15/2018
178Peter et. al., Are any of you buying more here? BladerunnerBladerunner17-5/15/2018
177While Nic sits there with thumb up butt...... healio.com DLBCL and follicular scaram(o)uche-5/4/2018
176MC of ~376M and EV of ~290M at current share price. TRIL gets no respect. :-semi_infinite -4/19/2018
175Surface Oncology (SURF) IPO priced at high end of range. Cheers, Tucktuck-4/19/2018
174List of CD47 programs by an unknown Trillium long, with some reasonably balancedtuck14/5/2018
173>> Another competitor that is no longer preclinical << Not a problescaram(o)uche-4/5/2018
172That's OK, as I've heard that Nic is developing a secret weapon (IgG3 coscaram(o)uche14/5/2018
171Another competitor that is no longer preclinical: SRF231 now in P1 Surface nottuck-4/5/2018
170Boehringer nabs OSE's preclinical SIRP-alpha immuno-oncology drug bioworld.scaram(o)uche-4/4/2018
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News